IP Library Granted Patent US 7,175,999
Granted Patent B2
US 7,175,999 · App. 10/617,351 · Granted Feb 13, 2007

Polynucleotide and polypeptide fat metabolism regulators and uses thereof

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,175,999
App. No.
10/617,351
Granted
Feb 13, 2007
Kind
B2
Abstract

In general, this invention relates to nucleic acid and amino acid sequences involved in fat metabolism regulation and the use of these sequences as targets for the diagnosis, treatment, and prevention of obesity and obesity-related diseases. In addition, the invention relates to screening methods for identifying modulators of body fat metabolism and the development of treatments for obesity and obesity-related diseases.

Claims (7)

1. A method of identifying a candidate compound that modulates fat metabolism, said method comprising

a) contacting a mammalian cell or a nematode cell with a candidate compound;

b) obtaining mRNA from said mammalian cell or said nematode cell;

c) contacting a microarray with said mRNA, wherein said microarray consists of at least two mammalian or nematode fat metabolism regulator nucleic acids or fragment thereof, wherein said fragment encodes at least 50 contiguous amino acids of a fat metabolism polypeptide, and wherein inactivation of each of said mammalian or nematode fat metabolism regulator nucleic acids results in an alteration in fat content of an organism compared to a control organism; and

d) detecting an alteration in cellular mRNA levels of at least two fat metabolism regulator nucleic acid molecules in said mammalian cell or said nematode cell contacted with said candidate compound compared to a control cell, wherein said alteration identifies the candidate compound as a candidate compound that modulates fat metabolism.

2. The microarray of claim 1 , wherein said mammalian cell is contacted with said candidate compound and said microarray consists of at least two mammalian fat metabolism regulator nucleic acids.

3. The microarray of claim 1 , wherein said nematode cell is contacted with said candidate compound and said microarray consists of at least two nematode fat metabolism regulator nucleic acids.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 22, 2017
From: PARTNERS HEALTHCARE INNOVATION
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 042784/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2004
From: RUVKUN, GARY; ASHRAFI, KAVEH
To: GENERAL HOSPITAL CORPORATION, THE
Reel/Frame 015224/0820 →
Continuity (2)
Provisional Application 6039515900 · Jul 11, 2002
Related Publication 20040158879A1 · Aug 12, 2004